ALDH1A1 and breast carcinoma: Associations between ALDH1A1 expression and molecular subtypes across human cancers were also identified (Fig. 5J), and a signature of increasing ALDH1A1 levels tended to be observed in all kinds of breast carcinoma (Fig. 5K), indicating the universal therapy-responsive role of ALDH1A1 in achieving better outcomes.